Specialists from the Johns Hopkins, Duke Univ. and Roswell Park Cancer Inst. have made major progress in prostate cancer treatment after a scientific study conducted on two hundred patients found that the blood vessel obstructing medication known as tasquinimod slackened the rate at which the condition progressed. Tasquinimod is additionally dubbed as the angiogenesis-resistant medication which wrings out blood circulation to the prostate tumors by hampering growth of novel blood vessels. All tumors require extensive nets of blood vessels for supplying nutrient forms. The multi-center studies conducted at 7 institutes inclusive of John Hopkins, registered people with prostate cancer among whom the condition had metastasized. They were given a single, day-to-day tablet tasquinimod to be  [...]

A recent study has shown that 3 lately revealed genetic variants could be contributory to pancreatic cancer risk. Investigators stated that this is the most large-scaled study conducted for identifying potentially risk heritable factors for this mystifying disease. Pancreatic cancer is one of the most lethal forms of cancer, with nearly two lakh newly evolved cases detected annually across the globe and virtually that many fatalities occurring due to this disease yearly. Figures reveal that below five percent of individuals detected with having pancreatic cancer survive for above 5 years following detection. The risk aspects for pancreatic cancer comprise of being diabetic, obese, smoking and a family past of pancreatic cancer. Though heritable factors appear to don a significant part  [...]

Prostate Cancer is the prevalent form of cancer affecting males which originates due to the unrestrained growth of the cells present in the prostate gland. Stages of Prostate Cancer The general staging involves the three categories, namely: T – The size of the primary tumor. N- If the cancer has metastasized to the adjacent lymph nodes. M- The appearance or non-appearance of remote metastasis. All these three are taken into consideration alongside the Gleason score. There are four groups for illustrating the local size of the prostate tumor that ranges between T1 to T4 with majority of them also having sub-groupings. T1 The tumor could not be felt during the DRE exam or viewed during transrectal ultrasound imaging. T1a The cancer has been accidentally detected at  [...]

Annually nearly thirty-five thousand men are detected with prostate cancer in the United Kingdom and more than ten thousand face fatalities due to the disease. The disease is known to affect the small gland that fits around the urethra and is responsible for the production of seminal fluid. Being treated early plays a decisive role. Nearly 98% of men that are detected with the cancer that has not metastasized beyond the gland could have a life expectancy rate of 5 years and more. This survival rate plummets to 30% when the cancer has metastasized. The diagnostic and treatment options for prostate cancer in its initial stages are stated below. Active Surveillance Active Surveillance generally translates to getting a PSA test done. The PSA test is conducted for checking any rise  [...]